# Optiray 300

NDC: 0019-1332
Generic name: Ioversol
Labeler / Manufacturer: Liebel-Flarsheim Company LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRA-ARTERIAL, INTRAVENOUS
Marketing started: 20120304

FDA application: NDA019710

## Active ingredients

- IOVERSOL: 636 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0019-1332"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0019-1332
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=549d38db-d4ed-4708-8f76-7cdaa157063f